1. Pink Sheet

Want To Avoid A Refuse-To-File? Submit ANDA In English, FDA Says

 
• By Derrick Gingery

Generic applications continue to be tripped up by failing to adhere to other well-known standards such as paying user fees, US agency says.

RulesRegulationsBooks_1200x675

Some of the seemingly simplest mistakes continue to trip up generic drug sponsors, forcing ANDAs to be rejected before a review can begin.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Generics

More from Biosimilars & Generics